CC MATE tablets: A Wellbalanced calcium supplement provides all the necessary nutrients and helps to prevent calcium deficiency

Authors

  • Govind Shukla Lactonova Nutripharm (P) Ltd, Makers of CC MATE tablet, 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.
  • C. Subrahmanyam Lactonova Nutripharm (P) Ltd, Makers of CC MATE tablet, 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.
  • Akanksha SonalKhess Lactonova Nutripharm (P) Ltd, Makers of CC MATE tablet, 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.
  • M. Dayanand Lactonova Nutripharm (P) Ltd, Makers of CC MATE tablet, 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.
  • Anusha Kandala Lactonova Nutripharm (P) Ltd, Makers of CC MATE tablet, 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.
  • G. Sravanthi Lactonova Nutripharm (P) Ltd, Makers of CC MATE tablet, 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.
  • C.J Sampath Kumar Lactonova Nutripharm (P) Ltd, Makers of CC MATE tablet, 81/3, IDA Mallapur, Hyderabad, Telangana, India-500 076.

Keywords:

Calcium, Oesteoporosis, Hypo and Hypercalcaemia, Parathyroid glands, CC Mate tablets

Abstract

Calcium is very essential in muscle contraction, oocyte activation, building strong bones and teeth, blood clotting, nerve impulse, transmission, regulating heart beat and fluid balance within cells. The requirements are greatest during the period of growth such as childhood, during pregnancy, when breast feeding. Long term of calcium deficiency can lead to oestoporosis in which the bone deteriorates and there is an increased rise of fractures. Eating a well-balanced calcium supplement can provide all the necessary nutrients and help prevent calcium deficiency. The present paper Reviews the Role of CC Mate tablets developed by R&D cell of
LactonovaNutripharm Pvt Ltd. Hyderabad in maintaining optimum health and wellbeing.

Dimensions

Published

2021-05-27

Issue

Vol. 11 No. 2 (2021): 2021 Volume -11 - Issue 2

Section

Articles
Copyright & Licensing
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 > >>